Aric leads diverse research programs spanning neurodevelopmental, neurodegenerative, and metabolic disorders. With over a decade of neuroscience experience, he leads programs from novel model development and characterization through IND-enabling therapeutic studies for both academic and industry partners. Passionate about advancing treatments, Aric applies his expertise to bridge basic science and therapeutic discovery for rare disease communities.
Aric graduated with his B.S. in physics at Georgia Institute of Technology, followed by a Master of Music at the University of Wisconsin-Milwaukee. Aric then studied bidirectional regulation of neurotransmitters in addiction at Marquette University for his graduate work, and addiction vulnerability at UNC Chapel Hill during a postdoctoral research fellowship. Aric worked as a Research Scientist at NeuroCycle Therapeutics managing in vivo and wet lab operations for non-opioid therapeutics research before joining the JAX Rare Disease Translational Center. In addition to his current role, Aric is pursuing his MBA at Husson University.